Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
—1,093.811,096.521,100.221,091.51——
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
—1,761.111,764.271,766.881,744.71——
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
—642.58644.87648.48640.18——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
—851.13855.66858.75845.56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
—3,211.833,227.213,268.383,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
—948.98948.58957.83941.97——
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
—1,474.521,479.031,481.041,466.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
—2,392.122,396.952,421.222,382.32——
Q1 2026 earnings • released • EPS beat +10,388.80% • Revenue beat +0.22%
See results
GSK:NYSE
GSK plc
$51.61
-1.34%
(-0.70) 1D
$51.60
-0.02% (-0.010)
After hours
Closed: May 1, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GSK...
Open
$51.80
High
$52.23
Low
$51.52
Mkt. cap
103.94B
Volume
3.94M
Dividend
3.44%
Quarterly dividend
$0.44
Ex dividend date
May 14, 2026
P/E ratio
13.32
52-wk high
$61.70
52-wk low
$35.45
EPS
$3.87
Beta
0.37
Shares outstanding
2.03B
No. of employees
67K
News stories
From sources across the web
Profile
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England. GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500. The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK. The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
About GSK plc
CEOEmma Walmsley | Emma Walmsley
Employees66.8K
FoundedDec 27, 2000
Headquarters-
SectorPharmaceutical industry
Websitegsk.com
Last report
Apr 29, 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
46.50/ (0.44 est.)GBP
+10,388.80%beat
Revenue / Estimate
7.63B/ (7.61B est.)GBP
+0.22%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
7.99B
8.55B
8.62B
7.63B
Cost of goods sold
2.16B
2.24B
2.62B
1.87B
Cost of revenue
2.16B
2.24B
2.62B
1.87B
Research and development expenses
1.54B
1.58B
2.14B
1.52B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.13B
2.16B
2.67B
2.08B
Operating expense
3.43B
3.23B
4.37B
2.99B
Total operating expenses
5.59B
5.46B
6.99B
4.86B
Operating income
2.39B
3.08B
1.63B
2.77B
Other non operating income
-
-
-21.00M
-
EBT including unusual items
1.89B
2.46B
950.00M
2.14B
EBT excluding unusual items
2.26B
2.94B
1.48B
2.62B
Income tax expense
241.00M
312.00M
223.00M
305.00M
Effective tax rate
12.77%
12.70%
23.47%
14.23%
Other operating expenses
-246.00M
-511.00M
-434.00M
-615.00M
Net income
1.44B
2.01B
636.00M
1.74B
Net profit margin
18.07%
23.55%
7.38%
22.77%
Earnings per share
0.46
0.55
-
-
Interest and investment income
50.00M
26.00M
17.00M
22.00M
Interest expense
-184.00M
-167.00M
-145.00M
-167.00M
Net interest expenses
-134.00M
-141.00M
-128.00M
-145.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
3.55B
3.82B
2.69B
3.23B
Gain or loss from assets sale
-
-
-40.00M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer